Abbott MediaRoom (Product) Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling - FDA approval of new software upgrade for Abbott's deep brain stimulation therapy enables advanced, patient-centric features for people living with Parkinson's disease and essential tremor Thu, 02 Aug 2018 09:00:00 -0400 Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S. - ALLOWS USERS TO WEAR THE SENSOR FOR UP TO 14 DAYS WITH HIGH ACCURACY Fri, 27 Jul 2018 13:00:00 -0400 Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease - Investigational Tendyne device is first and only repositionable and fully retrievable mitral valve replacement Thu, 26 Jul 2018 09:00:00 -0400 Abbott Introduces Breakthrough Point-of-Care Test, the m-PIMA™ HIV-1/2 Viral Load (VL), at AIDS 2018 Amsterdam NEW POINT-OF-CARE DIAGNOSTIC SOLUTION AIMS TO MAKE EFFECTIVE CARE MORE ACCESSIBLE FOR MILLIONS OF HIV PATIENTS, CONSISTENT WITH UNAIDS’ 90-90-90 GOALS Tue, 24 Jul 2018 09:00:00 -0400 Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves Thu, 12 Jul 2018 09:00:00 -0400